Skip to content

CALMARE THERAPEUTICS Inc

Delisted

CIK 102198fmd_04GA224K5CPMB3N693SYPX130RManufacturing · Surgical & Medical Instruments & ApparatusTemplate: Standard

Coverage: Feb 01, 2010 to Dec 31, 2016, 26 periods

Income Statement · Annual · Millions · USD
Line itemFY2011FY2012FY2013FY2014FY2015FY2016
Total revenues3–––––
Cost of revenue100000
Gross profit210111
Compensation and benefits2–––––
Total operating expenses640111
Operating income(4)(3)(3)(2)(3)(2)
Interest expense000111
Income before taxes(4)(3)(3)(3)(4)(4)
Net income(4)(3)(3)(3)(4)(4)
Net income to common shareholders(4)–––––
CALMARE THERAPEUTICS Inc financial statements · FinancialMD